Aivlosin
tylvalosin
Table of contents
Overview
Aivlosin is an antibiotic used to treat a number of infectious diseases in pigs, chickens, pheasants and turkeys.
In pigs, Aivlosin is used to treat and for metaphylaxis of several infections caused by bacteria that affect the lungs (i.e. swine enzootic pneumonia) or the intestinal tract (swine dysentery or porcine proliferative enteropathy). Metaphylaxis means giving a medicine to a group of animals, aiming to treat animals sick with an infection while controlling spread of the infection among the rest, some of whom may already be infected. Aivlosin improves the health and weight of the animals but it may not eliminate completely the bacteria that caused lung infection.
In chickens and pheasants, Aivlosin is used for treatment and metaphylaxis of lung infections caused by the bacterium Mycoplasma gallisepticum.
In turkeys, Aivlosin is used to treat lung infections caused by a bacterium, Ornithobacterium rhinotracheale, which can cause illness when it is complicated by other viral and bacterial infections.
Aivlosin contains the active substance tylvalosin (previously called acetylisovaleryltylosin).
Authorisation details
Product details | |
---|---|
Name |
Aivlosin
|
Agency product number |
EMEA/V/C/000083
|
Active substance |
tylvalosin
|
International non-proprietary name (INN) or common name |
tylvalosin
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QJ01FA92
|
Publication details | |
---|---|
Marketing-authorisation holder |
ECO Animal Health Europe Limited
|
Revision |
33
|
Date of issue of marketing authorisation valid throughout the European Union |
09/09/2004
|
Contact address |
ECO Animal Health Europe Limited |
Product information
12/03/2021 Aivlosin - EMEA/V/C/000083 - IA/0087
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Antiinfectives for systemic use
-
Antibacterials for systemic use
-
Macrolides
Therapeutic indication
Pigs
- Treatment and methaphylaxis of swine enzootic pneumonia;
- Treatment of porcine proliferative enteropathy (ileitis);
- Treatment and methaphylaxis of swine dysentery.
Chickens
- Treatment and methaphylaxis of respiratory disease associated with Mycoplasma gallisepticum in chickens.
Pheasants
- Treatment of respiratory disease associated with Mycoplasma gallisepticum.
Turkeys
- Treatment of respiratory disease associated with tylvalosin sensitive strains of Ornithobacterium rhinotracheale in turkeys.